A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer’s disease

Authors

Institutions

Publication Details

Journal
Frontiers in Neuroscience
Published
2024-11-27
DOI
https://doi.org/10.3389/fnins.2024.1460325
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer’s disease

Niayesh Mohebbi, Mahsa Panahishokouh, Fatemeh Mohammadian, Leyla Maleki
1 citations
Frontiers in Neuroscience
Schizophrenia research and treatment
0.39
article

A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer’s disease

Niayesh Mohebbi, Mahsa Panahishokouh, Fatemeh Mohammadian, Leyla Maleki
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in NeuroscienceVol. 18
Isfahan University of Medical Sciences (IR), Roozbeh Hospital (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 33%
Schizophrenia research and treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.